Profil
Reinhard Koenig served as President & CEO at Glycotex, Inc. and held director-level positions at Genentech, Inc. and Boehringer Mannheim Corp.
He was also Chief Scientific Officer at Collagen Aesthetics, Inc. and IMCOR Pharmaceutical Co. Additionally, he served as Vice President-Medical Affairs at Questcor Pharmaceuticals, Inc. and Chief Scientific Officer at Vivesto AB.
Koenig earned a doctorate degree from Philipps University of Marburg.
Anciens postes connus de Reinhard Koenig
| Sociétés | Poste | Fin |
|---|---|---|
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/04/2003 |
Collagen Aesthetics, Inc.
 Collagen Aesthetics, Inc. BiotechnologyHealth Technology Collagen Aesthetics, Inc. manufactures and markets biomedical devices for the treatment of defective, diseased, or aging human tissue | Directeur Technique/Scientifique/R&D | 01/04/1999 |
| VIVESTO AB | Directeur Technique/Scientifique/R&D | - |
| Boehringer Mannheim Corp. (California) | Directeur Technique/Scientifique/R&D | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Reinhard Koenig
| Philipps University of Marburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIVESTO AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |
IMCOR Pharmaceutical Co.
IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Health Technology |
Collagen Aesthetics, Inc.
Collagen Aesthetics, Inc. BiotechnologyHealth Technology Collagen Aesthetics, Inc. manufactures and markets biomedical devices for the treatment of defective, diseased, or aging human tissue | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Boehringer Mannheim Corp. (California) |
